| Issuer | % of Class | Filed |
|---|---|---|
|
Elicio Therapeutics, Inc.
13G/A
Amendment 2
ELTX · 28657F103
|
1.6% |
10/7/2025
Event 9/30/2025
|
|
Elicio Therapeutics, Inc.
13G/A
Amendment 1
ELTX · 28657F103
|
5.4% |
5/14/2025
Event 3/31/2025
|
|
Elicio Therapeutics, Inc.
13G
ELTX · 28657F103
|
5.5% |
1/7/2025
Event 12/8/2023
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.